oa SA Pharmaceutical Journal - Cancer vaccines - where are we now? : review
Chronic infection with viruses, bacteria or parasites, has long been recognised as a major causative factor in the initiation and / or promotion of the development of cancers worldwide. This has led to research in the areas of immunotherapy and prophylactic immunisation in an effort to reduce the world's cancer burden. Cancer vaccines differ from other conventional methods of managing cancer such as chemotherapy and radiotherapy in that they initiate a process of activating the body's own immune system.
Article metrics loading...